Oropouche orthobunyavirus
Oropouche orthobunyavirus (OOV), also known simply as Oropouche virus, is a member of the Orthobunyavirus genus in the Peribunyaviridae family. It is the causative agent of Oropouche fever, a disease characterized by symptoms such as fever, headache, dizziness, and joint pain. First identified in the 1950s in Trinidad and Tobago, the virus has since been reported in several countries across South and Central America, including Brazil, Peru, and Panama.
Transmission[edit | edit source]
OOV is primarily transmitted through the bite of infected Culicoides paraensis midges, a type of biting gnat. However, it can also be spread by Aedes and Culex mosquitoes. The virus can infect a wide range of hosts, including humans, monkeys, and birds, which serve as reservoirs for the virus, facilitating its spread.
Symptoms and Diagnosis[edit | edit source]
The incubation period of Oropouche fever is typically 4-8 days following the bite from an infected insect. Symptoms are often flu-like and include sudden onset of fever, headache, muscle and joint pains, dizziness, and photophobia. Some patients may also experience nausea, vomiting, and meningitis-like symptoms. Diagnosis of Oropouche fever is primarily based on clinical symptoms and is confirmed through laboratory tests such as RT-PCR, virus isolation, and serological assays to detect specific antibodies.
Treatment and Prevention[edit | edit source]
There is no specific antiviral treatment for Oropouche fever; management of the disease focuses on symptomatic relief, including rest, hydration, and the use of analgesics and antipyretics to relieve fever and pain. Prevention strategies are primarily aimed at controlling mosquito and midge populations and minimizing human exposure to these vectors. This includes the use of insect repellent, wearing long-sleeved clothing, and ensuring living areas are protected with window screens and mosquito nets.
Epidemiology[edit | edit source]
Since its discovery, Oropouche virus has been responsible for numerous outbreaks in the Amazon Basin, affecting tens of thousands of people. Urbanization and deforestation have been implicated in the increased incidence of Oropouche fever, as these activities expand human settlements into areas where the virus is endemic and increase the habitats for the virus's vectors.
Research[edit | edit source]
Research on Oropouche virus is ongoing, with studies focusing on understanding the virus's molecular biology, pathogenesis, and potential vaccine development. The emergence of Oropouche virus as a significant public health concern in South America underscores the need for continued surveillance, research, and development of effective control measures.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD